Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
United States
Age range
40 Years – 75 Years
Last updated on clinicaltrials.gov in January 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Christian Fulinara
University of California, San Diego